HomeCompareRMD vs FANG

RMD vs FANG: Dividend Comparison 2026

RMD yields 1.05% · FANG yields 2.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FANG wins by $81.78M in total portfolio value
10 years
RMD
RMD
● Live price
1.05%
Share price
$222.85
Annual div
$2.33
5Y div CAGR
35.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.5K
Annual income
$3,231.95
Full RMD calculator →
FANG
FANG
● Live price
2.11%
Share price
$191.49
Annual div
$4.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$81.81M
Annual income
$74,995,386.09
Full FANG calculator →

Portfolio growth — RMD vs FANG

📍 FANG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMDFANG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMD + FANG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMD pays
FANG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMD
Annual income on $10K today (after 15% tax)
$88.87/yr
After 10yr DRIP, annual income (after tax)
$2,747.16/yr
FANG
Annual income on $10K today (after 15% tax)
$179.77/yr
After 10yr DRIP, annual income (after tax)
$63,746,078.18/yr
At 15% tax rate, FANG beats the other by $63,743,331.02/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMD + FANG for your $10,000?

RMD: 50%FANG: 50%
100% FANG50/50100% RMD
Portfolio after 10yr
$40.92M
Annual income
$37,499,309.02/yr
Blended yield
91.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FANG right now

RMD
Analyst Ratings
16
Buy
14
Hold
5
Sell
Consensus: Buy
Price Target
$295.88
+32.8% upside vs current
Range: $265.00 — $345.00
Altman Z
11.6
Piotroski
7/9
FANG
Analyst Ratings
1
Strong
45
Buy
5
Hold
Consensus: Buy
Price Target
$182.64
-4.6% upside vs current
Range: $100.00 — $240.00
Altman Z
1.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMD buys
0
FANG buys
0
No recent congressional trades found for RMD or FANG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMDFANG
Forward yield1.05%2.11%
Annual dividend / share$2.33$4.05
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR35.9%100%
Portfolio after 10y$31.5K$81.81M
Annual income after 10y$3,231.95$74,995,386.09
Total dividends collected$10.2K$81.27M
Payment frequencyquarterlyquarterly
SectorHealthcareEnergy
Analyst consensusBuyBuy
Analyst price target$295.88$182.64

Year-by-year: RMD vs FANG ($10,000, DRIP)

YearRMD PortfolioRMD Income/yrFANG PortfolioFANG Income/yrGap
1← crossover$10,842$142.09$11,123$423.00$281.00FANG
2$11,797$195.66$12,781$879.44$984.00FANG
3$12,893$270.39$15,565$1,888.85$2.7KFANG
4$14,171$375.34$20,954$4,299.47$6.8KFANG
5$15,687$523.96$33,239$10,818.87$17.6KFANG
6$17,521$736.67$67,645$32,078.96$50.1KFANG
7$19,793$1,045.07$194,406$122,025.67$174.6KFANG
8$22,678$1,499.41$863,512$655,498.08$840.8KFANG
9$26,447$2,181.97$6,366,191$5,442,232.97$6.34MFANG
10$31,530$3,231.95$81,807,210$74,995,386.09$81.78MFANG

RMD vs FANG: Complete Analysis 2026

RMDHealthcare

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Full RMD Calculator →

FANGEnergy

Diamondback Energy, Inc., an independent oil and natural gas company, focuses on the acquisition, development, exploration, and exploitation of unconventional and onshore oil and natural gas reserves in the Permian Basin in West Texas. It focuses on the development of the Spraberry and Wolfcamp formations of the Midland basin; and the Wolfcamp and Bone Spring formations of the Delaware basin, which are part of the Permian Basin in West Texas and New Mexico. As of December 31, 2021, the company's total acreage position was approximately 524,700 gross acres in the Permian Basin; and estimated proved oil and natural gas reserves were 1,788,991 thousand barrels of crude oil equivalent. It also held working interests in 5,289 gross producing wells, as well as royalty interests in 6,455 additional wells. In addition, the company owns mineral interests approximately 930,871 gross acres and 27,027 net royalty acres in the Permian Basin and Eagle Ford Shale; and owns, operates, develops, and acquires midstream infrastructure assets, including 866 miles of crude oil gathering pipelines, natural gas gathering pipelines, and an integrated water system in the Midland and Delaware Basins of the Permian Basin. Diamondback Energy, Inc. was founded in 2007 and is headquartered in Midland, Texas.

Full FANG Calculator →
📬

Get this RMD vs FANG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMD vs SCHDRMD vs JEPIRMD vs ORMD vs KORMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.